Role of dimethylsulfoxide for management of chemotherapy extravasation

Journal of Oncology Pharmacy Practice

Volumn 10, Issue 4, 2004, Pages 197-200

  de Lemos, Mário L ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Anthracycline; Chemotherapy; Dimethylsulfoxide; Extravasation; Mitomycin

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DIMETHYL SULFOXIDE; DOXORUBICIN; EPIRUBICIN; MITOMYCIN;

ARTICLE; BULLOUS SKIN DISEASE; BURNING SENSATION; CLINICAL TRIAL; COOLING; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; EXTRAVASATION; HUMAN; PRIORITY JOURNAL; PRURITUS; SKIN IRRITATION; ULCER;

EID: 13444250056     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1191/1078155204jp137oa     Document Type: Article

References (27)

1. B.C. Cancer Agency Provincial Systemic Therapy Program. Provincial Systemic Therapy Program Policy III-20: Prevention and management of extravasation of chemotherapy. Vancouver, British Columbia: BC Cancer Agency; 1 February 2004.
2. Larson DL. Treatment of tissue extravasation by antitumor agents. Cancer 1982; 49(9): 1796-9.
3. Doff RT. Antidotes to vesicant chemotherapy extravasations. Blood Rev 1990; 4(1): 41-60.
4. Beckwith MC, Tyler LS. Extravasation. In: Cancer chemotherapy manual. Salt Lake City, Utah: Facts and Comparisons; August 2001.
5. The National Extravasation Information Service. Treating extravasation injuries. 2000-2004. Available from http://www.extravasation.org.uk/treating.htm; accessed 6 May, 2004.
6. Cox K, Stuart-Harris R, Abdini G, et al. The management of cytotoxic-drug extravasation: guidelines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 1988; 148: 185-9.
7. Fishman M, Mrozek-Orlowski M, for the Oncology Nursing Society. Cancer chemotherapy guidelines and recommendations for practice. 2nd ed. Pittsburgh, PA: Oncology Nursing Press, Inc; 1999. p. 32-41.
8. Bertelli G. Prevention and management of extravasation of cytotoxic drugs. Drug Saf 1995; 12(4): 245-55.
9. Larson DL. What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg 1985; 75(3 : 397-405.
10. Harwood KYS, Strauman JJ. Management of chemotherapy tissue extravasation. In: Detcher, Wernik, eds. Handbook of Hematology and Oncology Emergencies: Plenum Medical Book Co.; 1987. p. 331-41.
11. Harwood KV, Vito B, Brady P, et al. Management of doxorubicin extravasation. Oncol Nurs Forum 1989; 16(1): 10-1.
12. Harwood KV, Bachur N. Evaluation of dimethyl sulfoxide and local cooling as antidotes for doxorubicin extravasation in a pig model. Oncol Nurs Forum 1987; 14(1): 39-44.
13. Cox RF. Managing skin damage induced by doxorubicin hydrochloride and daunorubicin hydrochloride. Am J Hosp Pharm 1984; 41(11): 2410-4.
14. Ludwig CU, Stoll HR, Obrist R, et al. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole. Eur J Cancer Clin Oncol 1987; 23(3): 327-9.
15. Herrera D, Burnham N. DMSO and extravasation of mitomycin. Oncol Nurs Forum 1989; 16(2): 155.
16. Lawrence HJ, Walsh D, Zapotowski KA, et al. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol 1989; 23(5): 316-8.
17. Alberts DS, Dorr RT. Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncology Nursing Forum 1991; 18(4): 693-5.
18. Rospond RM, Engel LM. Dimethyl sulfoxide for treating anthracycline extravasation. Clin Pharm 1993; 12(8): 560-1.
19. St Germain B, Houlihan N, D'Amato S. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations. J Intravenous Nursing 1994; 17(5): 261-6.
20. Dini D, Forno G, Gozza A, et al. Combined management in the treatment of epidoxorubicin extravasation. A case report. Support Care Cancer 1995; 3(2): 150-2.
21. Comas D, Mateu J. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion. Ann Pharmacother 1996; 30(3): 244-6.
22. Berghammer P, Pohnl R, Baur M, et al. Docetaxel extravasation. Supportive Care in Cancer 2001; 9(2): 131-4.
23. Bos AM, van der Graaf WT, Willemse PH. A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane. Acta Oncol 2001; 40(4): 541-2.
24. Creus N, Mateu J, Masso J, et al. Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote. Pharm World Sci 2002; 24(5): 175-6.
25. Olver IN, Aisner J, Hament A, et al. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 1988; 6(11): 1732-5.
26. Bertelli G, Gozza A, Forno GB, et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995; 13(11): 2851-5.
27. Bertelli G, Dini D, Forno G, et al. Dimethylsulphoxide and cooling after extravasation of antitumour agents. Lancet 1993; 341(8852): 1098-9.